banner
600276.SS image

Jiangsu Hengrui Medicine Co., Ltd.

600276.SS

54.5

CNY
-1.10
(-1.98%)
Day's range
54.3
56
52 wk Range
37.24
57.53

Key ratios

P/E Ratio
50
Price/Book
7.25
Debt/Equity
0.13%
Return on Equity
15.30%
Dividend Yield
0.73%
EBITDA
7.95B

Statements Highlights

Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024
Total Revenue27,734,598,74725,905,526,37521,275,270,68122,819,784,74127,984,605,342
Gross Profit24,385,909,07822,163,727,82517,788,631,79119,294,536,95524,136,427,951
Operating Income7,007,072,3034,664,816,1274,111,959,9714,909,904,9267,490,632,003
Net Income6,328,383,2194,530,217,5503,906,375,0674,302,435,9306,336,527,014
Total Assets34,729,589,91539,266,221,70042,355,009,12743,784,506,63550,135,645,304
Total Current Liabilities3,771,593,0663,401,532,4543,639,219,6022,553,658,6283,633,595,722
Total Equity30,787,001,93835,571,807,92638,413,156,14241,033,086,44046,090,250,732
Free Cash Flow2,877,606,2742,554,180,820-726,913,080.166,159,873,3295,453,555,550
Cash from Operations3,431,934,8054,218,816,0531,265,264,6317,643,665,0747,422,753,038
Cash from Investing1,797,828,788-546,263,028.9390,289,3661,222,315,107-1,911,985,716.23
Cash from Financing291,188,280-998,321,816.5-318,770,209.45-3,144,426,297-1,550,590,025.88
Net Change in Cash5,431,873,0222,657,364,7671,417,281,1605,734,087,0213,967,577,847

Dividends

Analyst Recomendations